ctrl K

Petros Pharmaceuticals In... (PTPI)

NASDAQ: PTPI · Real-Time Price · USD

0.26

0.25 (2066.67%)

At close: May 01, 2025, 3:59 PM

0.27

2.90%

After-hours: May 01, 2025, 07:59 PM EDT

Petros Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	5.11B	5.82M	5.99M	7.81M	9.56M	15.58M	14.05M
Cost of Revenue	1.21B	1.63M	2.29M	1.6M	4.05M	7.43M	10.48M
Gross Profit	3.9B	4.19M	3.7M	6.21M	5.51M	8.15M	3.57M
Operating Income	-17.68B	-13.62M	-15.85M	-18.05M	-17.28M	-16.87M	-7.65M
Interest Income	371.77K	515.31K	14.19K	368.66K	3.05M	13.84M	11.86M
Pretax Income	-14.32B	-8.16M	-20.04M	-8.99M	-22.01M	-33.16M	-32.49M
Net Income	-14.32M	-8.16M	-27.04M	-9.36M	-20.59M	-32.51M	-32.47M
Selling & General & Admin	8.75B	9.26M	12.21M	15.59M	15.67M	19.73M	11.22M
Research & Development	2.62B	2.41M	1.74M	1.79M	459.64K	n/a	n/a
Other Expenses	9B	6.14M	5.6M	6.88M	6.66M	5.29M	n/a
Operating Expenses	20.37B	17.81M	19.55M	24.26M	22.8M	25.02M	11.22M
Interest Expense	560.91K	536.14K	596.02K	368.66K	3.05M	13.84M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-41.15K
Cost & Expenses	21.58B	19.44M	21.84M	25.86M	26.84M	32.45M	21.7M
Income Tax Expense	12.48B	n/a	7M	368.66K	-1.43M	-645.87K	-13.37K
Shares Outstanding (Basic)	80.26M	2.18M	2.07M	1.09M	970.76K	170.7K	100K
Shares Outstanding (Diluted)	80.26M	2.18M	2.07M	1.09M	970.76K	170.7K	100K
EPS (Basic)	-0.02	-6.35	-13.06	-8.59	-21.21	-190.46	-324.73
EPS (Diluted)	-0.02	-6.35	-13.06	-8.59	-21.21	-190.46	-324.73
EBITDA	-12.05B	-4.21M	-13.73M	-1.64M	-12.21M	-14M	373.58K
EBIT	-14.88B	-7.63M	-19.44M	-8.62M	-18.96M	-19.31M	-20.63M
Depreciation & Amortization	2.83B	3.42M	5.72M	6.98M	6.75M	5.32M	8.06M